Parathyroid cancer with MTOR gene mutation: Case report and review of the literature - 24/11/23
Doi : 10.1016/j.ando.2023.06.003
Júlia Stark a, 1, Judit Tőke a, 1, Gergely Huszty b, Péter Nagy c, Gábor Bedics c, d, Csaba Bödör c, d, József Tímár e, Miklós Tóth a, ⁎, 1 
a Department of Internal Medicine and Oncology, ENDO-ERN HCP, Faculty of Medicine, Semmelweis University, Budapest, Hungary
b Department of Surgery, Transplantation and Gastroenterology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
c Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary
d HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary
e Department of Pathology, Forensic and Insurance Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary
⁎Corresponding author. Department of Internal Medicine and Oncology, Semmelweis University, 2/a Korányi Sándor street, 1083 Budapest, Hungary.Department of Internal Medicine and Oncology, Semmelweis University2/a Korányi Sándor streetBudapest1083Hungary
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 6
P. 761-763 - décembre 2023 Retour au numéro
Article précédent
- Case report: Non-PTH-dependent hypercalcemia in pregnancy: Consider CYP24A1 mutations
- Madleen Lemaitre, Arnaud Lionet, Victor Fages, Marie-Christine Vantyghem, Damien Subtil, Anne Vambergue
- Parathyroid adenoma in the sternocleidomastoid muscle 30 years after thyroidectomy
- Matthieu Thumerel, Yaniss Belaroussi, Jared McSweeney, Magalie Haissaguerre
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?